Cogent Biosciences, Inc.
Recent Filings
All 584 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| S-8 | S-8 | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| 10-K | 10-K | Feb 17, 2026 |
| 8-K | 8-K | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Jan 30, 2026 |
| 4 | OWNERSHIP DOCUMENT | Jan 22, 2026 |
| 144 | — | Jan 22, 2026 |
| SCHEDULE 13D/A | — | Jan 22, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Kearns Evan | Chief Legal Officer | Sale | 65,000 @ $38.70 | 109,398 | Dec 26, 2025 |
| Green John L. | Chief Financial Officer | Sale | 77,000 @ $38.68 | 131,834 | Dec 26, 2025 |
| Sachs Jessica | Chief Medical Officer | Sale | 82,642 @ $38.70 | 133,938 | Dec 26, 2025 |
| Robinson John Edward | Chief Scientific Officer | Sale | 90,000 @ $38.74 | 140,002 | Dec 26, 2025 |
| Robinson John Edward | Chief Scientific Officer | Award / Grant | 320,000 | 370,000 | Dec 17, 2025 |
| Robbins Andrew R | President and CEO | Award / Grant | 840,000 | 1,025,000 | Dec 17, 2025 |
| Pinnow Cole | Chief Commercial Officer | Award / Grant | 50,000 | 97,450 | Dec 17, 2025 |
| Sachs Jessica | Chief Medical Officer | Award / Grant | 50,000 | 51,296 | Dec 17, 2025 |
| Green John L. | Chief Financial Officer | Award / Grant | 300,000 | 353,841 | Dec 17, 2025 |
| Fairmount Funds Management LLC | — | Purchase | 2,777,777 @ $9.00 | 9,003,418 | Jul 10, 2025 |